# Imunon, Inc.: Form 8-K, filed Jun 4, 2026

- Company: [Imunon, Inc.](/companies/imnn.md) (CIK 749647)
- Form: 8-K
- Filed: 2026-06-04
- Accepted by EDGAR: Jun 4, 2026, 08:00 ET
- Period: 2026-06-01
- Accession: 0001493152-26-027201
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/749647/000149315226027201/form8-k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/749647/000149315226027201/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 2.03: New direct financial obligation
- Item 3.02: Unregistered sale of equity
- Item 5.03: Amendment to articles or bylaws
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/749647/000149315226027201/form8-k.htm

Filed Jun 4, 2026.
Source: SEC EDGAR, the filing index for accession 0001493152-26-027201. Last ingested by Listed: Oct 27, 2026, 16:17 ET. No prices; not investment advice.